Merijn Klaassen
Director of Finance/CFO at EQT Life Sciences Group BV
Network origin in Merijn Klaassen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Twente
41
| College/University | Other Consumer Services | 41 |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
31
| Subsidiary | Investment Managers | 31 |
University of Tilburg
28
| College/University | Other Consumer Services | 28 |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.
22
| Subsidiary | Investment Managers | 22 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Merijn Klaassen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree | |
| Vrije Universiteit Amsterdam | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Technische Universiteit Eindhoven | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| Radboud University Nijmegen | College/University | Graduate Degree Graduate Degree Graduate Degree General Counsel | |
| PHILIPS NV | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Merck Ventures BV
 Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Analyst Private Equity Analyst Private Equity Analyst | |
ViCentra BV
 ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member Director/Board Member | |
Brabantse Ontwikkelings Maatschappij Holding BV
 Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance Brabantse Ontwikkelings Maatschappij Holding BV (BOM) is an industrial and economic development agency headquarterd in Tilburg in the southern Netherlands. Established in 1983, BOM is funded and financed by the Dutch State and the Province of Noord-Brabant. The firm offers a range of services designed to create, develop, maintain and improve the industrial structure of the region through four core activities: venture capital, foreign investment, new business and industrial parks. In particular BOM manages the Technostartersfonds, also known as the TechnoStars funds, which are regional venture capital investment vehicles based in Eindhoven. The investors are primarily institutions and high-net worth private individuals. | Investment Managers | Private Equity Investor Corporate Officer/Principal Human Resources Officer | |
| Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Nyenrode Business Universiteit | College/University | Undergraduate Degree Graduate Degree | |
| TRUE PARTNER CAPITAL HOLDING LIMITED | Investment Managers | Chief Investment Officer Chief Tech/Sci/R&D Officer | |
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Van Lanschot Kempen Investment Management NV
 Van Lanschot Kempen Investment Management NV Investment ManagersFinance Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients. | Investment Managers | Portfolio Manager-Fixed Income Portfolio Manager-Equities | |
Berenschot Groep BV
 Berenschot Groep BV Miscellaneous Commercial ServicesCommercial Services Berenschot Groep BV provides legal services. It offers services in the areas of additive manufacturing, benchmarking, business operations, change management, corporate social responsibility/sustainability, facility management, information management, leadership development, mergers and acquisitions, operational excellence, organizational design and structuring, organizational development, performance management, job evaluation and remuneration, policy research and evaluation, project grants, recovery and restructuring, and strategy formulation, as well as process, project and program management. The company was founded in 1938 and is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member Consultant / Advisor | |
| KUROS BIOSCIENCES AG | Biotechnology | Director/Board Member Chairman | |
| ERICSSON | Telecommunications Equipment | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Leiden | College/University | Undergraduate Degree Doctorate Degree | |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Kreatech Biotechnology BV
 Kreatech Biotechnology BV Medical/Nursing ServicesHealth Services Kreatech Biotechnology BV provides diagnostics detection products. It develops tools for labeling and detection of DNA, RNA, and proteins molecules. The company's products are used in the areas of Oncology, Haematology, and Pre-natal diagnostics. It offers services to the drug discovery, pharmaceutical, diagnostics, and life science companies. Kreatech Biotechnology was founded by Volkers Herman in 1990 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Chairman Director/Board Member | |
McKinsey & Co., Inc. (Belgium)
 McKinsey & Co., Inc. (Belgium) Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consultancy services. It serves businesses, governments, non governmental organizations, and non-profit organizations. The company was founded by James O. McKinsey in 1926 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Egle Therapeutics SAS
 Egle Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Health Economics Privak II NV
 Health Economics Privak II NV Finance/Rental/LeasingFinance Health Economics Privak II NV is a Belgian company that provides credit intermediation services. The private company is based in De Pinte, Belgium. The company was founded in 2017. | Finance/Rental/Leasing | Director/Board Member Director/Board Member | |
Xilis, Inc.
 Xilis, Inc. Medical SpecialtiesHealth Technology Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC. | Medical Specialties | Founder Director/Board Member | |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning. | Miscellaneous Commercial Services | President Director/Board Member | |
Neuravi Ltd.
 Neuravi Ltd. Medical SpecialtiesHealth Technology Neuravi Ltd. designs and develops medical devices for the treatment of acute stroke. Through its investment in the Neuravi Thromboembolic Initiative the company supports collaboration between engineers, clinicians and researchers to deepen the understanding of clot and occlusion dynamics to improve patient outcomes in stroke. Neuravi The company was founded by Mahmood K. Razav, Eamon Brady, John O'Shaughnessy and David Vale in 2009 and is headquartered in Galway, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
Mckinsey & Co. /Amsterdam/
 Mckinsey & Co. /Amsterdam/ Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., Mckinsey & Co. /Amsterdam/ provides management consultancy services. The company is based in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ATON | Pharmaceuticals: Major | Chairman Director/Board Member | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NEXSTIM PLC | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| TiasNimbas Business School BV | College/University | Corporate Officer/Principal Masters Business Admin | |
BMEYE BV
 BMEYE BV Electronic Equipment/InstrumentsElectronic Technology BMEYE BV operates as a non-invasive cardiovascular monitoring company. The firm manufactures and distributes non-invasive technology, hemodynamic monitoring equipment and related medical devices. It offers finger arterial pressure and cardiac output technologies. The company was founded in April 2005 and is headquartered in Amsterdam, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member | |
| OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ING BANK SLASKI S.A. | Regional Banks | Director/Board Member Corporate Officer/Principal |
Statistics
International
| Netherlands | 27 |
| Belgium | 8 |
| Switzerland | 5 |
| France | 4 |
| United States | 3 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 12 |
| Finance | 10 |
| Commercial Services | 6 |
| Electronic Technology | 5 |
Operational
| Director/Board Member | 248 |
| Corporate Officer/Principal | 132 |
| Graduate Degree | 70 |
| Private Equity Investor | 63 |
| Chairman | 43 |
Most connected contacts
| Insiders | |
|---|---|
| Jörg Neermann | 34 |
| Martijn Kleijwegt | 33 |
| René Kuijten | 30 |
| Rudy Dekeyser | 29 |
| Monika Bütler | 25 |
| John Paul de Koning | 21 |
| Steven ten Have | 18 |
| Eric A. van Amerongen | 18 |
| Kevin Chen | 17 |
| Anne Portwich | 16 |
| Vincent Brichard | 15 |
| Hans Clevers | 14 |
| Bruno Luc Myriam Holthof | 14 |
| Daniël Jan Ellens | 13 |
| F. Andre Jesualdo Benaroya | 13 |
- Stock Market
- Insiders
- Merijn Klaassen
- Company connections
